For companies in the Ozempic-fueled weight-loss economy, it's survival of the fittest

  • 📰 latimes
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 82%

Portugal Notícia Notícia

Portugal Últimas Notícias,Portugal Manchetes

As powerful anti-obesity drugs become more widely available, companies are repositioning themselves with new products and services.

Before he began taking Mounjaro last summer, Nick Lovell was the weight-loss economy's ideal customer. He signed up for WeightWatchers and bought 'Dr. Atkins' Diet Revolution' to try the low-carb regimen. He joined his first gym in middle school and has belonged to half a dozen others since. He paid for personal trainers and boutique fitness classes and underwent bariatric surgery in 2008. And yet, his 5-foot-9-inch frame stubbornly held onto its 258 pounds.

We’re actually thrilled at what lies ahead.” With many GLP-1 users reporting muscle loss as a side effect, Atkins is pushing its line of high-protein bars and shakes, “a deliciously easy way to meet your protein requirements to help you maintain lean muscle mass and bone health while you’re losing weight.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 11. in PT
 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Portugal Últimas Notícias, Portugal Manchetes